- Tabernero, J., Bang, Y., Van Cutsem, E., Fuchs, C. S., Janjigian, Y. Y., Bhagia, P., et al. (2021). KEYNOTE-859: A phase III study of pembrolizumab plus chemotherapy in gastric/gastroesophageal junction adenocarcinoma. Future Oncology. https://doi.org/10.2217/fon-2021-0176 (Article en premsa)
KEYNOTE-859: A phase III study of pembrolizumab plus chemotherapy in gastric/gastroesophageal junction adenocarcinoma
on 25 de maig de 2021
with No hi ha comentaris
Deixa un comentari